These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16829932)

  • 21. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Alzheimer's disease.
    Rossor MN
    Baillieres Clin Neurol; 1992 Nov; 1(3):517-34. PubMed ID: 1344201
    [No Abstract]   [Full Text] [Related]  

  • 23. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
    Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
    Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
    Tanahashi H; Tabira T
    Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New knowledge about amyloid can result in new treatment of Alzheimer disease].
    Jönhagen ME
    Lakartidningen; 2005 Oct 24-30; 102(43):3104-5. PubMed ID: 16302503
    [No Abstract]   [Full Text] [Related]  

  • 29. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
    Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Framing beta-amyloid.
    Hardy J
    Nat Genet; 1992 Jul; 1(4):233-4. PubMed ID: 1363811
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroinformatics: a new tool for studying the brain.
    Bloom FE; Morrison JH; Young WG
    J Affect Disord; 2006 May; 92(1):133-8. PubMed ID: 16488481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.
    Bayer TA; Breyhan H; Duan K; Rettig J; Wirths O
    Neurodegener Dis; 2008; 5(3-4):140-2. PubMed ID: 18322372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
    Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The amyloid code.
    Mandavilli A
    Nat Med; 2006 Jul; 12(7):747-51. PubMed ID: 16829921
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic modulation of senescent phenotypes in Homo sapiens.
    Martin GM
    Cell; 2005 Feb; 120(4):523-32. PubMed ID: 15734684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heterogeneity of brain aging: from senile dementia to successful aging].
    Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2953-4. PubMed ID: 16324376
    [No Abstract]   [Full Text] [Related]  

  • 39. Basic brain research shows its age.
    Smith DJ
    Am J Geriatr Psychiatry; 2005 Dec; 13(12):1025-6. PubMed ID: 16319294
    [No Abstract]   [Full Text] [Related]  

  • 40. Function of amyloid and amyloid protein precursor.
    Roos RA; Haan J
    Clin Neurol Neurosurg; 1992; 94 Suppl():S1-3. PubMed ID: 1320476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.